Multiplex Assays Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067361
  • December 2021
  • Biotechnology
  • 154 Pages
Report Description

This report is a comprehensive study that examines the Multiplex Assays industry in depth. With reference to key regions and major nations, the study specifies the product type of Multiplex Assays as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Multiplex Assays market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Multiplex Assays market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Multiplex Assays market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Multiplex Assays Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Multiplex Assays market study. The market dynamics and factors such as the threat of a Multiplex Assays substitute, the threat of new entrants into the Multiplex Assays market, buyer bargaining power, supplier bargaining power to Multiplex Assays providing companies, and internal rivalry among Multiplex Assays providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Multiplex Assays market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Multiplex Assays industry.
 
Multiplex Assays Market Key Trends Analysis

The important factors influencing the growth of the Multiplex Assays market have been examined in this report. The driving factors that are boosting demand for Multiplex Assayss and the restraining factors that are slowing growth of the Multiplex Assays industry are addressed in depth, as well as their implications for the worldwide Multiplex Assays market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Multiplex Assays Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Multiplex Assays industry. On the basis of current and future trends, all segments of the Multiplex Assays industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Multiplex Assays Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Multiplex Assays market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Multiplex Assays market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Multiplex Assays market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Multiplex Assays market. All important stakeholders in the Multiplex Assays value chain and technological ecosystem are expected to benefit from the insights offered in the Multiplex Assays market research study.

In order to provide a broader understanding of the top competitors in the Multiplex Assays market, the research includes a company market share analysis. Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina Inc (US), Bio-Rad Laboratories Inc. (US), Qiagen N.V. (Netherlands), Abcam plc (UK), Becton, Dickinson and Company (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Meso Scale Diagnostics (US), Randox Laboratories (UK), Quanterix (US), Bio-Techne Corporation (US), Olink (Sweden), DiaSorin S.p.A. (Italy), Seegene (South Korea), Promega Corporation (US), Siemens Healthineers (Germany), PerkinElmer Inc. (US), Shimadzu Biotech (Japan), Antigenix America Inc. (US), Enzo Life Sciences Inc. (US), Boster Biological Technology (US), AYOXXA Biosystems GmbH (Germany), Cayman Chemical Company (US). are among the major participants in the global Multiplex Assays industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina Inc (US), Bio-Rad Laboratories Inc. (US), Qiagen N.V. (Netherlands), Abcam plc (UK), Becton, Dickinson and Company (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Meso Scale Diagnostics (US), Randox Laboratories (UK), Quanterix (US), Bio-Techne Corporation (US), Olink (Sweden), DiaSorin S.p.A. (Italy), Seegene (South Korea), Promega Corporation (US), Siemens Healthineers (Germany), PerkinElmer Inc. (US), Shimadzu Biotech (Japan), Antigenix America Inc. (US), Enzo Life Sciences Inc. (US), Boster Biological Technology (US), AYOXXA Biosystems GmbH (Germany), Cayman Chemical Company (US).
 
Major Highlights of the Multiplex Assays Market report study:
  • An in-depth examination of the global Multiplex Assays industry will be published soon.
  • The study examines the global Multiplex Assays market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Multiplex Assays industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Multiplex Assays market is being shaped by several major trends.
  • The size of the Multiplex Assays market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Multiplex Assays market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Multiplex Assays market as follows:
Global Multiplex Assays Market: By Product Type

  • Protein Multiplex Assays
  • Nucleic Acid Multiplex Assays
  • Cell-Based Multiplex Assays

Global Multiplex Assays Market: By Application
  • Flow Cytometry
  • Fluorescence Detection
  • Luminescence
  • Multiplex Real-Time PCR
  • Other Technologies

Global Multiplex Assays Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Multiplex Assays market.
  • Universities and students
  • Other companies in the Multiplex Assays market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Multiplex Assays market

Manufacturers and Segments

  • Luminex Corporation (US)
  • Thermo Fisher Scientific Inc. (US)
  • Illumina Inc (US)
  • Bio-Rad Laboratories Inc. (US)
  • Qiagen N.V. (Netherlands)
  • Abcam plc (UK)
  • Becton
  • Dickinson and Company (US)
  • Merck KGaA (Germany)
  • Agilent Technologies Inc. (US)
  • Meso Scale Diagnostics (US)
  • Randox Laboratories (UK)
  • Quanterix (US)
  • Bio-Techne Corporation (US)
  • Olink (Sweden)
  • DiaSorin S.p.A. (Italy)
  • Seegene (South Korea)
  • Promega Corporation (US)
  • Siemens Healthineers (Germany)
  • PerkinElmer Inc. (US)
  • Shimadzu Biotech (Japan)
  • Antigenix America Inc. (US)
  • Enzo Life Sciences Inc. (US)
  • Boster Biological Technology (US)
  • AYOXXA Biosystems GmbH (Germany)
  • Cayman Chemical Company (US).
  • Protein Multiplex Assays
  • Nucleic Acid Multiplex Assays
  • Cell-Based Multiplex Assays
  • Flow Cytometry
  • Fluorescence Detection
  • Luminescence
  • Multiplex Real-Time PCR
  • Other Technologies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Multiplex Assays Market Snapshot
          2.1.1. Global Multiplex Assays Market By Protein Multiplex Assays,2019
               2.1.1.1.
               2.1.1.2.Protein Multiplex Assays
               2.1.1.3.Nucleic Acid Multiplex Assays
          2.1.2. Global Multiplex Assays Market By Flow Cytometry,2019
               2.1.2.1.
               2.1.2.2.Flow Cytometry
               2.1.2.3.Fluorescence Detection
               2.1.2.4.Luminescence
               2.1.2.5.Multiplex Real-Time PCR
          2.1.3. Global Multiplex Assays Market By End-use,2019
          2.1.4. Global Multiplex Assays Market By Geography,2019

3. Global Multiplex Assays Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Multiplex Assays Market Size (US$), By Protein Multiplex Assays, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Protein Multiplex Assays, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Protein Multiplex Assays, 2020
     4.2. Global Multiplex Assays Market Size (US$), By Protein Multiplex Assays, 2018 – 2028

5. Global Multiplex Assays Market Size (US$), By Flow Cytometry, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Flow Cytometry, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Flow Cytometry, 2020
     5.2. Global Multiplex Assays Market Size (US$), By Flow Cytometry, 2018 – 2028

6. Global Multiplex Assays Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Multiplex Assays Market Size (US$), By End-use, 2018 – 2028

7. Global Multiplex Assays Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Multiplex Assays Market Analysis, 2018 – 2028 
          7.2.1. North America Multiplex Assays Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Multiplex Assays Market Size (US$), By Protein Multiplex Assays, 2018 – 2028
          7.2.3. North America Multiplex Assays Market Size (US$), By Flow Cytometry, 2018 – 2028
          7.2.4. North America Multiplex Assays Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Multiplex Assays Market Analysis, 2018 – 2028 
          7.3.1.  Europe Multiplex Assays Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Multiplex Assays Market Size (US$), By Protein Multiplex Assays, 2018 – 2028
          7.3.3. Europe Multiplex Assays Market Size (US$), By Flow Cytometry, 2018 – 2028
          7.3.4. Europe Multiplex Assays Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Multiplex Assays Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Multiplex Assays Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Multiplex Assays Market Size (US$), By Protein Multiplex Assays, 2018 – 2028
          7.4.3. Asia Pacific Multiplex Assays Market Size (US$), By Flow Cytometry, 2018 – 2028
          7.4.4. Asia Pacific Multiplex Assays Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Multiplex Assays Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Multiplex Assays Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Multiplex Assays Market Size (US$), By Protein Multiplex Assays, 2018 – 2028
          7.5.3. Latin America Multiplex Assays Market Size (US$), By Flow Cytometry, 2018 – 2028
          7.5.4. Latin America Multiplex Assays Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Multiplex Assays Market Analysis, 2018 – 2028 
          7.6.1.  MEA Multiplex Assays Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Multiplex Assays Market Size (US$), By Protein Multiplex Assays, 2018 – 2028
          7.6.3. MEA Multiplex Assays Market Size (US$), By Flow Cytometry, 2018 – 2028
          7.6.4. MEA Multiplex Assays Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Multiplex Assays Providers
        8.4.1 Luminex Corporation (US)
                8.4.1.1 Business Description
                8.4.1.2 Luminex Corporation (US) Geographic Operations
                8.4.1.3 Luminex Corporation (US) Financial Information
                8.4.1.4 Luminex Corporation (US) Product Positions/Portfolio
                8.4.1.5 Luminex Corporation (US) Key Developments
        8.4.2 Thermo Fisher Scientific Inc. (US)
                8.4.2.1 Business Description
                8.4.2.2 Thermo Fisher Scientific Inc. (US) Geographic Operations
                8.4.2.3 Thermo Fisher Scientific Inc. (US) Financial Information
                8.4.2.4 Thermo Fisher Scientific Inc. (US) Product Positions/Portfolio
                8.4.2.5 Thermo Fisher Scientific Inc. (US) Key Developments
        8.4.3 Illumina Inc (US)
                8.4.3.1 Business Description
                8.4.3.2 Illumina Inc (US) Geographic Operations
                8.4.3.3 Illumina Inc (US) Financial Information
                8.4.3.4 Illumina Inc (US) Product Positions/Portfolio
                8.4.3.5 Illumina Inc (US) Key Developments
        8.4.4 Bio-Rad Laboratories Inc. (US)
                8.4.4.1 Business Description
                8.4.4.2 Bio-Rad Laboratories Inc. (US) Geographic Operations
                8.4.4.3 Bio-Rad Laboratories Inc. (US) Financial Information
                8.4.4.4 Bio-Rad Laboratories Inc. (US) Product Positions/Portfolio
                8.4.4.5 Bio-Rad Laboratories Inc. (US) Key Developments
        8.4.5 Qiagen N.V. (Netherlands)
                8.4.5.1 Business Description
                8.4.5.2 Qiagen N.V. (Netherlands) Geographic Operations
                8.4.5.3 Qiagen N.V. (Netherlands) Financial Information
                8.4.5.4 Qiagen N.V. (Netherlands) Product Positions/Portfolio
                8.4.5.5 Qiagen N.V. (Netherlands) Key Developments
        8.4.6 Abcam plc (UK)
                8.4.6.1 Business Description
                8.4.6.2 Abcam plc (UK) Geographic Operations
                8.4.6.3 Abcam plc (UK) Financial Information
                8.4.6.4 Abcam plc (UK) Product Positions/Portfolio
                8.4.6.5 Abcam plc (UK) Key Developments
        8.4.7 Becton
                8.4.7.1 Business Description
                8.4.7.2 Becton Geographic Operations
                8.4.7.3 Becton Financial Information
                8.4.7.4 Becton Product Positions/Portfolio
                8.4.7.5 Becton Key Developments
        8.4.8 Dickinson and Company (US)
                8.4.8.1 Business Description
                8.4.8.2 Dickinson and Company (US) Geographic Operations
                8.4.8.3 Dickinson and Company (US) Financial Information
                8.4.8.4 Dickinson and Company (US) Product Positions/Portfolio
                8.4.8.5 Dickinson and Company (US) Key Developments
        8.4.9 Merck KGaA (Germany)
                8.4.9.1 Business Description
                8.4.9.2 Merck KGaA (Germany) Geographic Operations
                8.4.9.3 Merck KGaA (Germany) Financial Information
                8.4.9.4 Merck KGaA (Germany) Product Positions/Portfolio
                8.4.9.5 Merck KGaA (Germany) Key Developments
        8.4.10 Agilent Technologies Inc. (US)
                8.4.10.1 Business Description
                8.4.10.2 Agilent Technologies Inc. (US) Geographic Operations
                8.4.10.3 Agilent Technologies Inc. (US) Financial Information
                8.4.10.4 Agilent Technologies Inc. (US) Product Positions/Portfolio
                8.4.10.5 Agilent Technologies Inc. (US) Key Developments
        8.4.11 Meso Scale Diagnostics (US)
                8.4.11.1 Business Description
                8.4.11.2 Meso Scale Diagnostics (US) Geographic Operations
                8.4.11.3 Meso Scale Diagnostics (US) Financial Information
                8.4.11.4 Meso Scale Diagnostics (US) Product Positions/Portfolio
                8.4.11.5 Meso Scale Diagnostics (US) Key Developments
        8.4.12 Randox Laboratories (UK)
                8.4.12.1 Business Description
                8.4.12.2 Randox Laboratories (UK) Geographic Operations
                8.4.12.3 Randox Laboratories (UK) Financial Information
                8.4.12.4 Randox Laboratories (UK) Product Positions/Portfolio
                8.4.12.5 Randox Laboratories (UK) Key Developments
        8.4.13 Quanterix (US)
                8.4.13.1 Business Description
                8.4.13.2 Quanterix (US) Geographic Operations
                8.4.13.3 Quanterix (US) Financial Information
                8.4.13.4 Quanterix (US) Product Positions/Portfolio
                8.4.13.5 Quanterix (US) Key Developments
        8.4.14 Bio-Techne Corporation (US)
                8.4.14.1 Business Description
                8.4.14.2 Bio-Techne Corporation (US) Geographic Operations
                8.4.14.3 Bio-Techne Corporation (US) Financial Information
                8.4.14.4 Bio-Techne Corporation (US) Product Positions/Portfolio
                8.4.14.5 Bio-Techne Corporation (US) Key Developments
        8.4.15 Olink (Sweden)
                8.4.15.1 Business Description
                8.4.15.2 Olink (Sweden) Geographic Operations
                8.4.15.3 Olink (Sweden) Financial Information
                8.4.15.4 Olink (Sweden) Product Positions/Portfolio
                8.4.15.5 Olink (Sweden) Key Developments
        8.4.16 DiaSorin S.p.A. (Italy)
                8.4.16.1 Business Description
                8.4.16.2 DiaSorin S.p.A. (Italy) Geographic Operations
                8.4.16.3 DiaSorin S.p.A. (Italy) Financial Information
                8.4.16.4 DiaSorin S.p.A. (Italy) Product Positions/Portfolio
                8.4.16.5 DiaSorin S.p.A. (Italy) Key Developments
        8.4.17 Seegene (South Korea)
                8.4.17.1 Business Description
                8.4.17.2 Seegene (South Korea) Geographic Operations
                8.4.17.3 Seegene (South Korea) Financial Information
                8.4.17.4 Seegene (South Korea) Product Positions/Portfolio
                8.4.17.5 Seegene (South Korea) Key Developments
        8.4.18 Promega Corporation (US)
                8.4.18.1 Business Description
                8.4.18.2 Promega Corporation (US) Geographic Operations
                8.4.18.3 Promega Corporation (US) Financial Information
                8.4.18.4 Promega Corporation (US) Product Positions/Portfolio
                8.4.18.5 Promega Corporation (US) Key Developments
        8.4.19 Siemens Healthineers (Germany)
                8.4.19.1 Business Description
                8.4.19.2 Siemens Healthineers (Germany) Geographic Operations
                8.4.19.3 Siemens Healthineers (Germany) Financial Information
                8.4.19.4 Siemens Healthineers (Germany) Product Positions/Portfolio
                8.4.19.5 Siemens Healthineers (Germany) Key Developments
        8.4.20 PerkinElmer Inc. (US)
                8.4.20.1 Business Description
                8.4.20.2 PerkinElmer Inc. (US) Geographic Operations
                8.4.20.3 PerkinElmer Inc. (US) Financial Information
                8.4.20.4 PerkinElmer Inc. (US) Product Positions/Portfolio
                8.4.20.5 PerkinElmer Inc. (US) Key Developments
        8.4.21 Shimadzu Biotech (Japan)
                8.4.21.1 Business Description
                8.4.21.2 Shimadzu Biotech (Japan) Geographic Operations
                8.4.21.3 Shimadzu Biotech (Japan) Financial Information
                8.4.21.4 Shimadzu Biotech (Japan) Product Positions/Portfolio
                8.4.21.5 Shimadzu Biotech (Japan) Key Developments
        8.4.22 Antigenix America Inc. (US)
                8.4.22.1 Business Description
                8.4.22.2 Antigenix America Inc. (US) Geographic Operations
                8.4.22.3 Antigenix America Inc. (US) Financial Information
                8.4.22.4 Antigenix America Inc. (US) Product Positions/Portfolio
                8.4.22.5 Antigenix America Inc. (US) Key Developments
        8.4.23 Enzo Life Sciences Inc. (US)
                8.4.23.1 Business Description
                8.4.23.2 Enzo Life Sciences Inc. (US) Geographic Operations
                8.4.23.3 Enzo Life Sciences Inc. (US) Financial Information
                8.4.23.4 Enzo Life Sciences Inc. (US) Product Positions/Portfolio
                8.4.23.5 Enzo Life Sciences Inc. (US) Key Developments
        8.4.24 Boster Biological Technology (US)
                8.4.24.1 Business Description
                8.4.24.2 Boster Biological Technology (US) Geographic Operations
                8.4.24.3 Boster Biological Technology (US) Financial Information
                8.4.24.4 Boster Biological Technology (US) Product Positions/Portfolio
                8.4.24.5 Boster Biological Technology (US) Key Developments
        8.4.25 AYOXXA Biosystems GmbH (Germany)
                8.4.25.1 Business Description
                8.4.25.2 AYOXXA Biosystems GmbH (Germany) Geographic Operations
                8.4.25.3 AYOXXA Biosystems GmbH (Germany) Financial Information
                8.4.25.4 AYOXXA Biosystems GmbH (Germany) Product Positions/Portfolio
                8.4.25.5 AYOXXA Biosystems GmbH (Germany) Key Developments
        8.4.26 Cayman Chemical Company (US).
                8.4.26.1 Business Description
                8.4.26.2 Cayman Chemical Company (US). Geographic Operations
                8.4.26.3 Cayman Chemical Company (US). Financial Information
                8.4.26.4 Cayman Chemical Company (US). Product Positions/Portfolio
                8.4.26.5 Cayman Chemical Company (US). Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Multiplex Assays Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Multiplex Assays Market Revenue, By Protein Multiplex Assays, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Multiplex Assays Market Revenue, By Flow Cytometry, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Multiplex Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Multiplex Assays Market Revenue, By Protein Multiplex Assays, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Multiplex Assays Market Revenue, By Flow Cytometry, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Multiplex Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Multiplex Assays Market Revenue, By Protein Multiplex Assays, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Multiplex Assays Market Revenue, By Flow Cytometry, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Multiplex Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Multiplex Assays Market Revenue, By Protein Multiplex Assays, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Multiplex Assays Market Revenue, By Flow Cytometry, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Multiplex Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Multiplex Assays Market Revenue, By Protein Multiplex Assays, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Multiplex Assays Market Revenue, By Flow Cytometry, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Multiplex Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Multiplex Assays: Market Segmentation 
FIG. 2 Global Multiplex Assays Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Multiplex Assays Market, By Protein Multiplex Assays, 2019 (US$ Mn) 
FIG. 5 Global Multiplex Assays Market, By Flow Cytometry, 2019 (US$ Mn) 
FIG. 6 Global Multiplex Assays Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Multiplex Assays Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Multiplex Assays Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Multiplex Assays Providers, 2019
FIG. 11 Global Multiplex Assays Market Revenue Contribution, By Protein Multiplex Assays, 2019 & 2028 (Value %) 
FIG. 12 Global Multiplex Assays Market Revenue Contribution, By Flow Cytometry, 2019 & 2028 (Value %) 
FIG. 13 Global Multiplex Assays Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Multiplex Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Multiplex Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Multiplex Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Multiplex Assays Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Multiplex Assays Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Multiplex Assays market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Multiplex Assays Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Multiplex Assays Market Value, By Segment1, 2018 – 2028
TABLE  North America Multiplex Assays Market Value, By Segment2, 2018 – 2028
TABLE  North America Multiplex Assays Market Value, By Country, 2018 – 2028
TABLE  Europe Multiplex Assays Market Value, By Segment1, 2018 – 2028
TABLE  Europe Multiplex Assays Market Value, By Segment2, 2018 – 2028
TABLE  Europe Multiplex Assays Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Multiplex Assays Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Multiplex Assays Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Multiplex Assays Market Value, By Country, 2018 – 2028
TABLE  Latin America Multiplex Assays Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Multiplex Assays Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Multiplex Assays Market Value, By Country, 2018 – 2028
TABLE  MEA Multiplex Assays Market Value, By Segment1, 2018 – 2028
TABLE  MEA Multiplex Assays Market Value, By Segment2, 2018 – 2028
TABLE  MEA Multiplex Assays Market Value, By Country, 2018 – 2028
TABLE  Luminex Corporation (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific Inc. (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Illumina Inc (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories Inc. (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Qiagen N.V. (Netherlands): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abcam plc (UK): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Becton: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dickinson and Company (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck KGaA (Germany): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Agilent Technologies Inc. (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Meso Scale Diagnostics (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Randox Laboratories (UK): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Quanterix (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Techne Corporation (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Olink (Sweden): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DiaSorin S.p.A. (Italy): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Seegene (South Korea): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Promega Corporation (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Siemens Healthineers (Germany): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  PerkinElmer Inc. (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shimadzu Biotech (Japan): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Antigenix America Inc. (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Enzo Life Sciences Inc. (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boster Biological Technology (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AYOXXA Biosystems GmbH (Germany): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cayman Chemical Company (US).: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Multiplex Assays Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Multiplex Assays Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Multiplex Assays Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Multiplex Assays Market, By Geography, 2019 (US$ Mn)
FIG.  Global Multiplex Assays Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Multiplex Assays Providers, 2016
FIG.  Global Multiplex Assays Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Protein Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Nucleic Acid Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cell-Based Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Multiplex Assays Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Flow Cytometry Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Fluorescence Detection Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Luminescence Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Multiplex Real-Time PCR Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Multiplex Assays Market Value, 2018 – 2028, (US$ Mn)